Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.75 |
| ▸ | TFEB | P19484 | 1/20 | 0.74 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.72 |
| ▸ | MAPT | P10636 | 5/20 | 0.66 |
| ▸ | NPC1 | O15118 | 3/20 | 0.66 |
| ▸ | RAB9A | P51151 | 2/20 | 0.66 |
| ▸ | LMNA | P02545 | 2/20 | 0.66 |
| ▸ | BCHE | P06276 | 1/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.64 |
| ▸ | ATM | Q13315 | 1/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | LY96 | Q9Y6Y9 | 1/20 | 0.62 |
| ▸ | MAOB | P27338 | 3/20 | 0.60 |
| ▸ | AR | P10275 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 5/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6737719 | 1.00 | NFE2L2 (0.75) | NFE2L2TFEBKDM4EMAPTNPC1 | |
| SCHEMBL10438847 | 0.87 | ALDH1A1 (0.58) | NFE2L2TFEBKDM4EMAPTNPC1 | |
| SCHEMBL69522 | 0.87 | ALDH1A1 (0.58) | NFE2L2TFEBKDM4EMAPTNPC1 | |
| SCHEMBL5598849 | 0.86 | NFE2L2 (1.00) | NFE2L2TFEBKDM4EMAPTNPC1 | |
| SCHEMBL5598851 | 0.86 | NFE2L2 (1.00) | NFE2L2TFEBKDM4EMAPTNPC1 | |
| Cyclopropane SCHEMBL11842187 | 0.85 | NFE2L2 (0.60) | NFE2L2TFEBKDM4EMAPTNPC1 | |
| SCHEMBL2744047 | 0.85 | NFE2L2 (1.00) | NFE2L2TFEBKDM4EMAPTNPC1 | |
| SCHEMBL30307386 | 0.85 | NFE2L2 (1.00) | NFE2L2TFEBKDM4EMAPTNPC1 | |
| SCHEMBL2744044 | 0.85 | NFE2L2 (1.00) | NFE2L2TFEBKDM4EMAPTNPC1 | |
| SCHEMBL29805195 | 0.85 | NFE2L2 (1.00) | NFE2L2TFEBKDM4EMAPTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 244 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119980263-A | Sun-screening agent, sun-screening composition and preparation method of sun-screening agent | 牛吉娜 | 2025-05-13 | — | — | CN | claimed |
| CN-117986487-A | Modified polyglycolic acid raw material composition with improved compressive property, modified polyglycolic acid, preparation method and application thereof | 中国石油化工股份有限公司 | 2024-05-07 | — | — | CN | claimed |
| CN-110540505-B | Green and clean production process of isooctyl p-methoxycinnamate | 安徽圣诺贝化学科技有限公司 | 2022-07-08 | — | — | CN | claimed |
| CN-110040833-B | Preparation method of heavy metal ion trapping agent for electroplating wastewater | 襄阳先创环保科技有限公司 | 2021-09-03 | — | — | CN | claimed |
| US-20080020004-A1 | Hair-Treatment Agent Comprising Terpolymer Of Vinylpyrrolidone, Methacrylamide And Vinylimidazole And Active Ingredients And Additives | WELLA AG (DE) | 2008-01-24 | — | — | US | claimed |
| EP-1584323-B1 | Use of N-hydroxyalkyl-O-benzylchitosans in hair treatment | WELLA AG (DE) | 2007-10-24 | — | — | EP | claimed |
| EP-1463482-A4 | PHOTOSTABLE SUNSCREEN COMPOSITIONS AND METHODS OF STBAILIZING | AVON PROD INC (US) | 2005-03-16 | — | — | EP | claimed |
| EP-1463482-A1 | PHOTOSTABLE SUNSCREEN COMPOSITIONS AND METHODS OF STBAILIZING | AVON PRODUCTS, INC. (US) | 2004-10-06 | — | — | EP | claimed |
| WO-2003051318-A1 | PHOTOSTABLE SUNSCREEN COMPOSITIONS AND METHODS OF STBAILIZING | AVON PRODUCTS, INC. (US) | 2003-06-26 | — | — | WO | claimed |
| US-20260000076-A1 | ANTIMICROBIAL COMBINATIONS | CLARIANT INT LTD (CH) | 2026-01-01 | — | — | US | disclosed |
| EP-4637352-A2 | ANTIMICROBIAL COMBINATIONS | CLARIANT INTERNATIONAL LTD (CH) | 2025-10-29 | — | — | EP | disclosed |
| EP-4598500-A1 | COMBINATION COMPRISING A GLUCAMIDE AND A CO-EMULSIFIER | CLARIANT INTERNATIONAL LTD (CH) | 2025-08-13 | — | — | EP | disclosed |
| EP-4245293-B1 | USE OF SUGAR AMINES AS COMPLEXING AGENTS | CLARIANT INT LTD (CH) | 2025-08-06 | — | — | EP | disclosed |
| EP-4557953-A1 | ANTIMICROBIAL COMBINATIONS | CLARIANT INTERNATIONAL LTD (CH) | 2025-05-28 | — | — | EP | disclosed |
| EP-0389434-A1 | Bis(1-hydrocarbyloxy-2,2,6,6-tetramethylpiperidin-4-yl)-amine Derivatives and Stabilized compositions | CIBA-GEIGY AG (CH) | 1990-09-26 | — | — | EP | disclosed |
| EP-0389422-A2 | Stabilizers derived from N-hydroxy hindered amines by Michael addition reactions | CIBA-GEIGY AG (CH) | 1990-09-26 | — | — | EP | disclosed |
| EP-0389430-A1 | N-hydrocarbyloxy hindered amine light stabilizers substituted with phosphorus moieties | CIBA-GEIGY AG (CH) | 1990-09-26 | — | — | EP | disclosed |
| EP-0354234-A1 | NEW AMINES, THEIR USE AND PREPARATION | KabiVitrum AB (SE) | 1990-02-14 | — | — | EP | disclosed |
| WO-1989006644-A1 | NEW AMINES, THEIR USE AND PREPARATION | KABIVITRUM AB (SE) | 1989-07-27 | — | — | WO | disclosed |
| EP-0325571-A1 | New amines, their use and preparation | Kabi Pharmacia AB (SE) | 1989-07-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260000076-A1 | ANTIMICROBIAL COMBINATIONS | FFAR1, ELOVL3, ACAD11 | NFE2L2 1500/4885TFEB 2984/4885KDM4E 3135/4885 |
| US-20080020004-A1 | Hair-Treatment Agent Comprising Terpolymer Of Vinylpyrrolidone, Methacrylamide And Vinylimidazole And Active Ingredients And Additives | PLOD3, POLR1C, PTMA | NFE2L2 4676/4885TFEB 2572/4885KDM4E 1686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.